Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study.

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Inflammatory markers in population studies of aging. Ageing Res Rev (2010) 2.57

Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study. J Clin Hypertens (Greenwich) (2011) 2.04

The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women. AIDS (2011) 1.94

Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res (2014) 1.56

Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide. J Immunol (2012) 1.19

Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management. Heart Fail Rev (2012) 1.14

Heart failure with preserved ejection fraction in the elderly: scope of the problem. Heart Fail Rev (2012) 1.04

Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium. Circ Res (2014) 1.03

Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2013) 1.02

Information encoded in a network of inflammation proteins predicts clinical outcome after myocardial infarction. BMC Med Genomics (2011) 1.01

Lung function and risk for heart failure among older adults: the Health ABC Study. Am J Med (2011) 0.99

Aging and energetics' 'Top 40' future research opportunities 2010-2013. F1000Res (2014) 0.98

Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart Fail Rev (2014) 0.95

Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem. J Geriatr Cardiol (2015) 0.95

Positioning of inflammatory biomarkers in the heart failure landscape. J Cardiovasc Transl Res (2013) 0.93

Heart failure with preserved ejection fraction in the elderly: scope of the problem. J Mol Cell Cardiol (2015) 0.93

Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study. Am Heart J (2012) 0.89

Fatigue, inflammation, and projected mortality in heart failure. J Card Fail (2012) 0.87

The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction. Neth Heart J (2016) 0.86

The demographic and medical correlates of plasma aβ40 and aβ42. Alzheimer Dis Assoc Disord (2013) 0.86

Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice. Lab Invest (2012) 0.84

Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults. Am Heart J (2015) 0.84

Biomarkers in heart failure with preserved ejection fraction. Neth Heart J (2016) 0.83

Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study. Circ Heart Fail (2013) 0.83

Trajectories of inflammatory markers and cognitive decline over 10 years. Neurobiol Aging (2014) 0.81

Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania. Clin Interv Aging (2015) 0.81

Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction. Curr Heart Fail Rep (2015) 0.80

Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol (2015) 0.80

Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Kidney Dis (2014) 0.80

TV Watching, but Not Physical Activity, Is Associated With Change in Kidney Function in Older Adults. J Phys Act Health (2014) 0.80

Declines in inflammation predict greater white matter microstructure in older adults. Neurobiol Aging (2014) 0.80

Detecting the patient at risk of heart failure. J Am Coll Cardiol (2010) 0.79

Changes in cardiopulmonary reserve and peripheral arterial function concomitantly with subclinical inflammation and oxidative stress in patients with heart failure with preserved ejection fraction. Int J Vasc Med (2014) 0.79

Breakthrough in heart failure with preserved ejection fraction: are we there yet? Korean J Intern Med (2015) 0.78

Inflammation and oxidative stress caused by nitric oxide synthase uncoupling might lead to left ventricular diastolic and systolic dysfunction in patients with hypertension. J Geriatr Cardiol (2015) 0.78

Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure. BMC Cardiovasc Disord (2016) 0.77

Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine. Biomedicine (Taipei) (2015) 0.77

Association of Serum Erythropoietin With Cardiovascular Events, Kidney Function Decline, and Mortality: The Health Aging and Body Composition Study. Circ Heart Fail (2016) 0.77

A novel synthetic mono-carbonyl analogue of curcumin, A13, exhibits anti-inflammatory effects in vivo by inhibition of inflammatory mediators. Inflammation (2012) 0.77

Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure. J Am Heart Assoc (2016) 0.76

Waon therapy attenuates cardiac hypertrophy and promotes myocardial capillary growth in hypertensive rats: a comparative study with fluvastatin. Heart Vessels (2015) 0.76

Usefulness of cell-mediated immune function in risk stratification for patients with advanced heart failure. Am Heart J (2016) 0.75

Incident heart failure in relation to vascular disease: insights from the Health, Aging, and Body Composition Study. Eur J Heart Fail (2014) 0.75

Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review. Heart Fail Rev (2016) 0.75

Pathophysiology of heart failure and frailty: a common inflammatory origin? Aging Cell (2017) 0.75

Red cell distribution width and mortality in acute heart failure patients with preserved and reduced ejection fraction. ESC Heart Fail (2016) 0.75

Cardiovascular biomarkers and their utility in the older adult. Curr Cardiovasc Risk Rep (2012) 0.75

Prognostic value of increased carbohydrate antigen in patients with heart failure. World J Cardiol (2014) 0.75

Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis. ESC Heart Fail (2017) 0.75

Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction. J Transl Med (2016) 0.75

Update on heart failure with preserved ejection fraction. Curr Cardiovasc Risk Rep (2013) 0.75

Sodium restriction in heart failure: benefit or harm? Curr Treat Options Cardiovasc Med (2014) 0.75

Diastolic dysfunction and contrast-induced nephropathy in patients undergoing coronary angiography. Herz (2014) 0.75

Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction. J Am Heart Assoc (2017) 0.75

Heart failure with preserved ejection fraction: a nephrologist-directed primer. Heart Fail Rev (2017) 0.75

Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc (2017) 0.75

Heart Failure with Preserved Ejection Fraction in Older Adults. Heart Fail Clin (2017) 0.75

Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study. Dis Markers (2017) 0.75

Interleukin-19 is cardioprotective in dominant negative cyclic adenosine monophosphate response-element binding protein-mediated heart failure in a sex-specific manner. World J Cardiol (2017) 0.75

Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. J Am Heart Assoc (2017) 0.75

Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure. J Geriatr Cardiol (2017) 0.75

Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training. Oxid Med Cell Longev (2017) 0.75

Skeletal muscle alterations in HFrEF vs. HFpEF. Curr Heart Fail Rep (2017) 0.75

The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24

Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation (2007) 20.44

Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med (1999) 18.50

Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37

Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med (2008) 9.62

Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 5.65

A practical solution to the pervasive problems of p values. Psychon Bull Rev (2007) 5.64

Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol (2000) 5.59

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis (2000) 4.88

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation (2003) 4.67

Inflammation as a cardiovascular risk factor. Circulation (2004) 4.26

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation (2003) 4.09

Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 3.80

Systemic effects of smoking. Chest (2007) 3.63

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol (1996) 3.47

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation (1998) 3.14

Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol (2002) 3.05

Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation (1998) 2.77

Bayesian information criterion for censored survival models. Biometrics (2000) 2.75

Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol (2008) 2.74

Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med (2008) 2.65

Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation (2006) 2.53

Serum albumin: relationship to inflammation and nutrition. Semin Dial (2005) 2.41

Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail (2008) 2.33

A comparison of imputation techniques for handling missing predictor values in a risk model with a binary outcome. Stat Methods Med Res (2007) 2.31

Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A (1995) 2.05

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation (2002) 1.94

C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation (2005) 1.92

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol (1998) 1.75

Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation (2002) 1.41

Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation (2005) 1.40

Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr Diabetes Rev (2006) 1.30

Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol (2007) 1.27

Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence. Arterioscler Thromb Vasc Biol (2006) 1.26

Cytokines and myocardial dysfunction: state of the art. J Card Fail (2008) 1.18

TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling. Am J Physiol Heart Circ Physiol (2002) 1.17

Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. Diabetologia (2007) 1.10

C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study. Eur J Heart Fail (2007) 1.10

Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J (2001) 1.05

Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail (2008) 1.03

Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance. Coron Artery Dis (2008) 1.01

Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. Arterioscler Thromb Vasc Biol (2002) 0.98

Current perspectives on cardiac function in patients with diastolic heart failure. Circulation (2009) 0.98

Endothelial function, CRP and oxidative stress in chronic kidney disease. J Nephrol (2005) 0.98

Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome. Am J Hypertens (2007) 0.98

Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension. J Hum Hypertens (2007) 0.96

Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol (1998) 0.95

Tumor necrosis factor alpha (TNF alpha) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity. J Mol Cell Cardiol (1997) 0.91

Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation. Hypertens Res (2008) 0.87

Primary and secondary prevention of heart failure with statins. Expert Rev Cardiovasc Ther (2006) 0.83

Polymorphisms of angiotensinogen and angiotensin-converting enzyme associated with lower extremity arterial disease in the Health, Aging and Body Composition study. J Hum Hypertens (2007) 0.82

The role of statins in the prevention of heart failure after acute coronary syndrome. Heart Fail Clin (2008) 0.80

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Cardiac resynchronization in chronic heart failure. N Engl J Med (2002) 17.52

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med (2006) 16.17

Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30

Gait speed and survival in older adults. JAMA (2011) 15.01

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47

Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med (2010) 11.99

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70

Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet (2009) 8.42

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med (2007) 7.69

The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2006) 7.38

Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med (2013) 7.30

Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med (2009) 7.06

Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep (2006) 6.98

Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA (2006) 6.93

Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc (2006) 6.81

Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc (2005) 6.73

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci (2006) 6.61

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58

Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med (2010) 6.47

Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci (2005) 6.42

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 6.30

Intra-individual change over time in DNA methylation with familial clustering. JAMA (2008) 6.17

Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci (2006) 6.08

Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med (2002) 5.98

Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96

Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation (2008) 5.95

Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation (2010) 5.70

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47

Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol (2009) 5.41

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA (2003) 5.30

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol (2006) 5.28

Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA (2011) 5.21

High-throughput mapping of a dynamic signaling network in mammalian cells. Science (2005) 5.21

Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20

Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20

Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med (2008) 5.14

Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation (2007) 5.10

Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr (2008) 5.01

High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98

Inflammation as a risk factor for atrial fibrillation. Circulation (2003) 4.95

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation (2009) 4.87

Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78

A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet (2008) 4.75

The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA (2004) 4.73

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation (2003) 4.67

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63

Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet (2009) 4.56